Hong Kong Stock Market | BeiGene-B (02135.HK) rises over 7% in the afternoon and reaches a licensing deal with Tubulis again. The company reached a cooperation agreement with Merck at the beginning of the month.

According to the Securities Times APP, Betta Pharmaceuticals - B (02135.HK) rose more than 7% in the afternoon, up 4.07% as of the time of publication, reporting at 26.58 Hong Kong dollars, with a turnover of 1673.54 million Hong Kong dollars.